Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 15, 2019 07:45 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics Schedules First Quarter 2019 Financial Results Conference Call for April 30, 2019

CARLSBAD, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its first quarter earnings results after market close...
April 15, 2019 07:30 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Gram-Negative Panel

CARLSBAD, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that it...
February 21, 2019 16:05 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics Reports Fourth Quarter and Full Year 2018 Results

CARLSBAD, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
February 21, 2019 16:03 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics Announces Expansion of Executive Leadership Team

CARLSBAD, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced the...
February 20, 2019 16:55 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics to Participate in Upcoming Investor Conferences

CARLSBAD, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the...
February 07, 2019 16:43 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics Schedules Fourth Quarter and Full Year 2018 Financial Results Conference Call for February 21, 2019

CARLSBAD, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its fourth quarter earnings results after market close...
January 08, 2019 08:00 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2018

CARLSBAD, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided...
December 26, 2018 08:00 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Fungal Pathogen Panel

Two of Three ePlex Blood Culture Identification Panels Now Cleared for Marketing in the U.S. CARLSBAD, Calif., Dec. 26, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading...
December 20, 2018 14:15 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Gram-Positive Panel

CARLSBAD, Calif., Dec. 20, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that it...
December 19, 2018 17:22 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics to Present at the J.P. Morgan Healthcare Conference

CARLSBAD, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the...